APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Valsartan

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Valsartan Industry Growth and Trends Forecast to 2032

Report ID 174045020129 December 2025116 pages

Choose your research edition.

Industry ResearchValsartan Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Valsartan Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Valsartan Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valsartan Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Valsartan Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Valsartan market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Valsartan is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Valsartan is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Valsartan is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Valsartan include Alembic Pharmaceuticals, Amneal Pharmaceuticals, Aurobindo Pharma, HETERO, Huaren Pharmaceutical, Jubilant Pharma, LG Life Sciences, Lupin and Macleods Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Valsartan market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Valsartan market size, estimates, and forecasts are presented in terms of sales volume (K Pcs) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Valsartan market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Valsartan.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Valsartan market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Valsartan Market by Company

Alembic Pharmaceuticals

Amneal Pharmaceuticals

Aurobindo Pharma

HETERO

Huaren Pharmaceutical

Jubilant Pharma

LG Life Sciences

Lupin

Macleods Pharmaceuticals

Square Pharmaceuticals

Torrent Pharmaceuticals

Unichem Laboratories

Mylan

Novartis

Sun Pharmaceutical

Teva

Zhejiang Huahai Pharmaceutical

Valsartan Segment by Type

80 mg Tablets

40 mg Tablets

320 mg Tablets

160 mg Tablets

Valsartan Segment by Application

Heart Failure

Heart Attack

Hypertension

Valsartan Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valsartan market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valsartan and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valsartan.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Valsartan manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Valsartan in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 80 mg Tablets Table 2. Major Company of 40 mg Tablets Table 3. Major Company of 320 mg Tablets Table 4. Major Company of 160 mg Tablets Table 5. Global Valsartan Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Valsartan Sales by Type (2021-2026) & (K Pcs) Table 7. Global Valsartan Sales Market Share in Volume by Type (2021-2026) Table 8. Global Valsartan Sales by Type (2021-2026) & (US$ Million) Table 9. Global Valsartan Sales Market Share in Value by Type (2021-2026) Table 10. Global Valsartan Price by Type (2021-2026) & (US$/Pcs) Table 11. Global Valsartan Sales by Type (2027-2032) & (K Pcs) Table 12. Global Valsartan Sales Market Share in Volume by Type (2027-2032) Table 13. Global Valsartan Sales by Type (2027-2032) & (US$ Million) Table 14. Global Valsartan Sales Market Share in Value by Type (2027-2032) Table 15. Global Valsartan Price by Type (2027-2032) & (US$/Pcs) Table 16. North America Valsartan Sales by Type (2021-2026) & (K Pcs) Table 17. North America Valsartan Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Valsartan Sales by Type (2021-2026) & (K Pcs) Table 19. Europe Valsartan Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Valsartan Sales by Type (2021-2026) & (K Pcs) Table 21. Asia-Pacific Valsartan Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Valsartan Sales by Type (2021-2026) & (K Pcs) Table 23. Latin America Valsartan Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Valsartan Sales by Type (2021-2026) & (K Pcs) Table 25. Middle East and Africa Valsartan Sales by Type (2021-2026) & (US$ Million) Table 26. Valsartan Industry Trends Table 27. Valsartan Industry Drivers Table 28. Valsartan Industry Opportunities and Challenges Table 29. Valsartan Industry Restraints Table 30. Global Valsartan Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Valsartan Revenue Market Share by Company (2021-2026) Table 32. Global Valsartan Sales by Company (2021-2026) & (K Pcs) Table 33. Global Valsartan Sales Share by Company (2021-2026) Table 34. Global Valsartan Market Price by Company (2021-2026) & (US$/Pcs) Table 35. Global Valsartan Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Valsartan Major Company Production Sites and Headquarters Table 37. Global Valsartan Company, Product Type & Application Table 38. Global Valsartan Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Valsartan by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Valsartan Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Valsartan Sales by Region (2021-2026) & (K Pcs) Table 43. Global Valsartan Sales Market Share in Volume by Region (2021-2026) Table 44. Global Valsartan Sales by Region (2021-2026) & (US$ Million) Table 45. Global Valsartan Sales Market Share in Value by Region (2021-2026) Table 46. Global Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 47. Global Valsartan Sales by Region (2027-2032) & (K Pcs) Table 48. Global Valsartan Sales Market Share in Volume by Region (2027-2032) Table 49. Global Valsartan Sales by Region (2027-2032) & (US$ Million) Table 50. Global Valsartan Sales Market Share in Value by Region (2027-2032) Table 51. Global Valsartan Sales (K Pcs), Value (US$ Million), Price (US$/Pcs) and Gross Margin (2027-2032) Table 52. Global Valsartan Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Valsartan Sales by Application (2021-2026) & (K Pcs) Table 54. Global Valsartan Sales Market Share in Volume by Application (2021-2026) Table 55. Global Valsartan Sales by Application (2021-2026) & (US$ Million) Table 56. Global Valsartan Sales Market Share in Value by Application (2021-2026) Table 57. Global Valsartan Price by Application (2021-2026) & (US$/Pcs) Table 58. Global Valsartan Sales by Application (2027-2032) & (K Pcs) Table 59. Global Valsartan Sales Market Share in Volume by Application (2027-2032) Table 60. Global Valsartan Sales by Application (2027-2032) & (US$ Million) Table 61. Global Valsartan Sales Market Share in Value by Application (2027-2032) Table 62. Global Valsartan Price by Application (2027-2032) & (US$/Pcs) Table 63. North America Valsartan Sales by Application (2021-2026) & (K Pcs) Table 64. North America Valsartan Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Valsartan Sales by Application (2021-2026) & (K Pcs) Table 66. Europe Valsartan Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Valsartan Sales by Application (2021-2026) & (K Pcs) Table 68. Asia-Pacific Valsartan Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Valsartan Sales by Application (2021-2026) & (K Pcs) Table 70. Latin America Valsartan Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Valsartan Sales by Application (2021-2026) & (K Pcs) Table 72. Middle East and Africa Valsartan Sales by Application (2021-2026) & (US$ Million) Table 73. Alembic Pharmaceuticals Company Information Table 74. Alembic Pharmaceuticals Business Overview Table 75. Alembic Pharmaceuticals Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 76. Alembic Pharmaceuticals Valsartan Product Portfolio Table 77. Alembic Pharmaceuticals Recent Development Table 78. Amneal Pharmaceuticals Company Information Table 79. Amneal Pharmaceuticals Business Overview Table 80. Amneal Pharmaceuticals Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 81. Amneal Pharmaceuticals Valsartan Product Portfolio Table 82. Amneal Pharmaceuticals Recent Development Table 83. Aurobindo Pharma Company Information Table 84. Aurobindo Pharma Business Overview Table 85. Aurobindo Pharma Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 86. Aurobindo Pharma Valsartan Product Portfolio Table 87. Aurobindo Pharma Recent Development Table 88. HETERO Company Information Table 89. HETERO Business Overview Table 90. HETERO Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 91. HETERO Valsartan Product Portfolio Table 92. HETERO Recent Development Table 93. Huaren Pharmaceutical Company Information Table 94. Huaren Pharmaceutical Business Overview Table 95. Huaren Pharmaceutical Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 96. Huaren Pharmaceutical Valsartan Product Portfolio Table 97. Huaren Pharmaceutical Recent Development Table 98. Jubilant Pharma Company Information Table 99. Jubilant Pharma Business Overview Table 100. Jubilant Pharma Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 101. Jubilant Pharma Valsartan Product Portfolio Table 102. Jubilant Pharma Recent Development Table 103. LG Life Sciences Company Information Table 104. LG Life Sciences Business Overview Table 105. LG Life Sciences Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 106. LG Life Sciences Valsartan Product Portfolio Table 107. LG Life Sciences Recent Development Table 108. Lupin Company Information Table 109. Lupin Business Overview Table 110. Lupin Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 111. Lupin Valsartan Product Portfolio Table 112. Lupin Recent Development Table 113. Macleods Pharmaceuticals Company Information Table 114. Macleods Pharmaceuticals Business Overview Table 115. Macleods Pharmaceuticals Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 116. Macleods Pharmaceuticals Valsartan Product Portfolio Table 117. Macleods Pharmaceuticals Recent Development Table 118. Square Pharmaceuticals Company Information Table 119. Square Pharmaceuticals Business Overview Table 120. Square Pharmaceuticals Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 121. Square Pharmaceuticals Valsartan Product Portfolio Table 122. Square Pharmaceuticals Recent Development Table 123. Torrent Pharmaceuticals Company Information Table 124. Torrent Pharmaceuticals Business Overview Table 125. Torrent Pharmaceuticals Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 126. Torrent Pharmaceuticals Valsartan Product Portfolio Table 127. Torrent Pharmaceuticals Recent Development Table 128. Unichem Laboratories Company Information Table 129. Unichem Laboratories Business Overview Table 130. Unichem Laboratories Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 131. Unichem Laboratories Valsartan Product Portfolio Table 132. Unichem Laboratories Recent Development Table 133. Mylan Company Information Table 134. Mylan Business Overview Table 135. Mylan Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 136. Mylan Valsartan Product Portfolio Table 137. Mylan Recent Development Table 138. Novartis Company Information Table 139. Novartis Business Overview Table 140. Novartis Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 141. Novartis Valsartan Product Portfolio Table 142. Novartis Recent Development Table 143. Sun Pharmaceutical Company Information Table 144. Sun Pharmaceutical Business Overview Table 145. Sun Pharmaceutical Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 146. Sun Pharmaceutical Valsartan Product Portfolio Table 147. Sun Pharmaceutical Recent Development Table 148. Teva Company Information Table 149. Teva Business Overview Table 150. Teva Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 151. Teva Valsartan Product Portfolio Table 152. Teva Recent Development Table 153. Zhejiang Huahai Pharmaceutical Company Information Table 154. Zhejiang Huahai Pharmaceutical Business Overview Table 155. Zhejiang Huahai Pharmaceutical Valsartan Sales (K Pcs), Revenue (US$ Million), Price (US$/Pcs) and Gross Margin (2021-2026) Table 156. Zhejiang Huahai Pharmaceutical Valsartan Product Portfolio Table 157. Zhejiang Huahai Pharmaceutical Recent Development Table 158. North America Valsartan Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 159. North America Valsartan Sales by Country (2021-2026) & (K Pcs) Table 160. North America Valsartan Sales Market Share by Country (2021-2026) Table 161. North America Valsartan Sales Forecast by Country (2027-2032) & (K Pcs) Table 162. North America Valsartan Sales Market Share Forecast by Country (2027-2032) Table 163. North America Valsartan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. North America Valsartan Market Size by Country (2021-2026) & (US$ Million) Table 165. North America Valsartan Market Share by Country (2021-2026) Table 166. North America Valsartan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. North America Valsartan Market Share Forecast by Country (2027-2032) Table 168. Europe Valsartan Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 169. Europe Valsartan Sales by Country (2021-2026) & (K Pcs) Table 170. Europe Valsartan Sales Market Share by Country (2021-2026) Table 171. Europe Valsartan Sales Forecast by Country (2027-2032) & (K Pcs) Table 172. Europe Valsartan Sales Market Share Forecast by Country (2027-2032) Table 173. Europe Valsartan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 174. Europe Valsartan Market Size by Country (2021-2026) & (US$ Million) Table 175. Europe Valsartan Market Share by Country (2021-2026) Table 176. Europe Valsartan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 177. Europe Valsartan Market Share Forecast by Country (2027-2032) Table 178. Asia-Pacific Valsartan Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 179. Asia-Pacific Valsartan Sales by Country (2021-2026) & (K Pcs) Table 180. Asia-Pacific Valsartan Sales Market Share by Country (2021-2026) Table 181. Asia-Pacific Valsartan Sales Forecast by Country (2027-2032) & (K Pcs) Table 182. Asia-Pacific Valsartan Sales Market Share Forecast by Country (2027-2032) Table 183. Asia-Pacific Valsartan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 184. Asia-Pacific Valsartan Market Size by Country (2021-2026) & (US$ Million) Table 185. Asia-Pacific Valsartan Market Share by Country (2021-2026) Table 186. Asia-Pacific Valsartan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 187. Asia-Pacific Valsartan Market Share Forecast by Country (2027-2032) Table 188. Latin America Valsartan Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 189. Latin America Valsartan Sales by Country (2021-2026) & (K Pcs) Table 190. Latin America Valsartan Sales Market Share by Country (2021-2026) Table 191. Latin America Valsartan Sales Forecast by Country (2027-2032) & (K Pcs) Table 192. Latin America Valsartan Sales Market Share Forecast by Country (2027-2032) Table 193. Latin America Valsartan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 194. Latin America Valsartan Market Size by Country (2021-2026) & (US$ Million) Table 195. Latin America Valsartan Market Share by Country (2021-2026) Table 196. Latin America Valsartan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 197. Latin America Valsartan Market Share Forecast by Country (2027-2032) Table 198. Middle East and Africa Valsartan Market Size Growth Rate (CAGR) by Country (K Pcs): 2021 VS 2025 VS 2032 Table 199. Middle East and Africa Valsartan Sales by Country (2021-2026) & (K Pcs) Table 200. Middle East and Africa Valsartan Sales Market Share by Country (2021-2026) Table 201. Middle East and Africa Valsartan Sales Forecast by Country (2027-2032) & (K Pcs) Table 202. Middle East and Africa Valsartan Sales Market Share Forecast by Country (2027-2032) Table 203. Middle East and Africa Valsartan Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 204. Middle East and Africa Valsartan Market Size by Country (2021-2026) & (US$ Million) Table 205. Middle East and Africa Valsartan Market Share by Country (2021-2026) Table 206. Middle East and Africa Valsartan Market Size Forecast by Country (2027-2032) & (US$ Million) Table 207. Middle East and Africa Valsartan Market Share Forecast by Country (2027-2032) Table 208. Key Raw Materials Table 209. Raw Materials Key Suppliers Table 210. Valsartan Distributors List Table 211. Valsartan Customers List Table 212. Research Programs/Design for This Report Table 213. Authors List of This Report Table 214. Secondary Sources Table 215. Primary Sources List of Figures Figure 1. Valsartan Image Figure 2. Global Valsartan Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valsartan Market Size (2021-2032) & (US$ Million) Figure 4. Global Valsartan Sales (2021-2032) & (K Pcs) Figure 5. 80 mg Tablets Image Figure 6. Global 80 mg Tablets Sales YoY Growth (2021-2032) & (K Pcs) Figure 7. 40 mg Tablets Image Figure 8. Global 40 mg Tablets Sales YoY Growth (2021-2032) & (K Pcs) Figure 9. 320 mg Tablets Image Figure 10. Global 320 mg Tablets Sales YoY Growth (2021-2032) & (K Pcs) Figure 11. 160 mg Tablets Image Figure 12. Global 160 mg Tablets Sales YoY Growth (2021-2032) & (K Pcs) Figure 13. Global Valsartan Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Valsartan Market Share by Type 2025 VS 2032 Figure 15. North America Valsartan Sales Market Share in Volume by Type in 2025 Figure 16. North America Valsartan Sales Market Share in Value by Type in 2025 Figure 17. Europe Valsartan Sales Market Share in Volume by Type in 2025 Figure 18. Europe Valsartan Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Valsartan Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Valsartan Sales Market Share in Value by Type in 2025 Figure 21. Latin America Valsartan Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Valsartan Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Valsartan Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Valsartan Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Valsartan Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Heart Failure Image Figure 28. Global Heart Failure Sales YoY Growth (2021-2032) & (K Pcs) Figure 29. Heart Attack Image Figure 30. Global Heart Attack Sales YoY Growth (2021-2032) & (K Pcs) Figure 31. Hypertension Image Figure 32. Global Hypertension Sales YoY Growth (2021-2032) & (K Pcs) Figure 33. Global Valsartan Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Valsartan Market Share by Application 2025 VS 2032 Figure 35. North America Valsartan Sales Market Share in Volume by Application in 2025 Figure 36. North America Valsartan Sales Market Share in Value by Application in 2025 Figure 37. Europe Valsartan Sales Market Share in Volume by Application in 2025 Figure 38. Europe Valsartan Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Valsartan Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Valsartan Sales Market Share in Value by Application in 2025 Figure 41. Latin America Valsartan Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Valsartan Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Valsartan Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Valsartan Sales Market Share in Value by Application in 2025 Figure 45. North America Valsartan Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 46. North America Valsartan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Valsartan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Valsartan Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Valsartan Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 50. Europe Valsartan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Valsartan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Valsartan Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Valsartan Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 54. Asia-Pacific Valsartan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Valsartan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Valsartan Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Valsartan Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 58. Latin America Valsartan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Valsartan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Valsartan Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Valsartan Sales by Country: 2021 VS 2025 VS 2032 (K Pcs) Figure 62. Middle East and Africa Valsartan Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Valsartan Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Valsartan Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Valsartan Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Valsartan Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 80 mg Tablets
  • 40 mg Tablets
  • 320 mg Tablets
  • 160 mg Tablets
Applications
  • Heart Failure
  • Heart Attack
  • Hypertension
Companies covered
  • Alembic Pharmaceuticals
  • Amneal Pharmaceuticals
  • Aurobindo Pharma
  • HETERO
  • Huaren Pharmaceutical
  • Jubilant Pharma
  • LG Life Sciences
  • Lupin
  • Macleods Pharmaceuticals
  • Square Pharmaceuticals
  • Torrent Pharmaceuticals
  • Unichem Laboratories
  • Mylan
  • Novartis
  • Sun Pharmaceutical
  • Teva
  • Zhejiang Huahai Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Valsartan Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Valsartan Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Valsartan Market by Type
  6. 1.3.1 80 mg Tablets
  7. 1.3.2 40 mg Tablets
  8. 1.3.3 320 mg Tablets
  9. 1.3.4 160 mg Tablets
  10. 1.4 Global Valsartan Market Size by Type
  11. 1.4.1 Global Valsartan Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Valsartan Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Valsartan Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Valsartan Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Valsartan Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Valsartan Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Valsartan Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Valsartan Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Valsartan Industry Trends
  2. 2.2 Valsartan Industry Drivers
  3. 2.3 Valsartan Industry Opportunities and Challenges
  4. 2.4 Valsartan Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Valsartan Revenue (2021-2026)
  2. 3.2 Global Top Players by Valsartan Sales (2021-2026)
  3. 3.3 Global Top Players by Valsartan Price (2021-2026)
  4. 3.4 Global Valsartan Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Valsartan Major Company Production Sites & Headquarters
  6. 3.6 Global Valsartan Company, Product Type & Application
  7. 3.7 Global Valsartan Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Valsartan Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Valsartan Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Valsartan Tier 1, Tier 2, and Tier 3
4 Valsartan Regional Status and Outlook
  1. 4.1 Global Valsartan Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Valsartan Historic Market Size by Region
  3. 4.2.1 Global Valsartan Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Valsartan Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Valsartan Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Valsartan Forecasted Market Size by Region
  7. 4.3.1 Global Valsartan Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Valsartan Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Valsartan Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Valsartan by Application
  1. 5.1 Valsartan Market by Application
  2. 5.1.1 Heart Failure
  3. 5.1.2 Heart Attack
  4. 5.1.3 Hypertension
  5. 5.2 Global Valsartan Market Size by Application
  6. 5.2.1 Global Valsartan Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Valsartan Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Valsartan Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Valsartan Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Valsartan Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Valsartan Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Valsartan Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Valsartan Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Alembic Pharmaceuticals
  2. 6.1.1 Alembic Pharmaceuticals Company Information
  3. 6.1.2 Alembic Pharmaceuticals Business Overview
  4. 6.1.3 Alembic Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Alembic Pharmaceuticals Valsartan Product Portfolio
  6. 6.1.5 Alembic Pharmaceuticals Recent Developments
  7. 6.2 Amneal Pharmaceuticals
  8. 6.2.1 Amneal Pharmaceuticals Company Information
  9. 6.2.2 Amneal Pharmaceuticals Business Overview
  10. 6.2.3 Amneal Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Amneal Pharmaceuticals Valsartan Product Portfolio
  12. 6.2.5 Amneal Pharmaceuticals Recent Developments
  13. 6.3 Aurobindo Pharma
  14. 6.3.1 Aurobindo Pharma Company Information
  15. 6.3.2 Aurobindo Pharma Business Overview
  16. 6.3.3 Aurobindo Pharma Valsartan Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Aurobindo Pharma Valsartan Product Portfolio
  18. 6.3.5 Aurobindo Pharma Recent Developments
  19. 6.4 HETERO
  20. 6.4.1 HETERO Company Information
  21. 6.4.2 HETERO Business Overview
  22. 6.4.3 HETERO Valsartan Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 HETERO Valsartan Product Portfolio
  24. 6.4.5 HETERO Recent Developments
  25. 6.5 Huaren Pharmaceutical
  26. 6.5.1 Huaren Pharmaceutical Company Information
  27. 6.5.2 Huaren Pharmaceutical Business Overview
  28. 6.5.3 Huaren Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Huaren Pharmaceutical Valsartan Product Portfolio
  30. 6.5.5 Huaren Pharmaceutical Recent Developments
  31. 6.6 Jubilant Pharma
  32. 6.6.1 Jubilant Pharma Company Information
  33. 6.6.2 Jubilant Pharma Business Overview
  34. 6.6.3 Jubilant Pharma Valsartan Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Jubilant Pharma Valsartan Product Portfolio
  36. 6.6.5 Jubilant Pharma Recent Developments
  37. 6.7 LG Life Sciences
  38. 6.7.1 LG Life Sciences Company Information
  39. 6.7.2 LG Life Sciences Business Overview
  40. 6.7.3 LG Life Sciences Valsartan Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 LG Life Sciences Valsartan Product Portfolio
  42. 6.7.5 LG Life Sciences Recent Developments
  43. 6.8 Lupin
  44. 6.8.1 Lupin Company Information
  45. 6.8.2 Lupin Business Overview
  46. 6.8.3 Lupin Valsartan Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Lupin Valsartan Product Portfolio
  48. 6.8.5 Lupin Recent Developments
  49. 6.9 Macleods Pharmaceuticals
  50. 6.9.1 Macleods Pharmaceuticals Company Information
  51. 6.9.2 Macleods Pharmaceuticals Business Overview
  52. 6.9.3 Macleods Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Macleods Pharmaceuticals Valsartan Product Portfolio
  54. 6.9.5 Macleods Pharmaceuticals Recent Developments
  55. 6.10 Square Pharmaceuticals
  56. 6.10.1 Square Pharmaceuticals Company Information
  57. 6.10.2 Square Pharmaceuticals Business Overview
  58. 6.10.3 Square Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Square Pharmaceuticals Valsartan Product Portfolio
  60. 6.10.5 Square Pharmaceuticals Recent Developments
  61. 6.11 Torrent Pharmaceuticals
  62. 6.11.1 Torrent Pharmaceuticals Company Information
  63. 6.11.2 Torrent Pharmaceuticals Business Overview
  64. 6.11.3 Torrent Pharmaceuticals Valsartan Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Torrent Pharmaceuticals Valsartan Product Portfolio
  66. 6.11.5 Torrent Pharmaceuticals Recent Developments
  67. 6.12 Unichem Laboratories
  68. 6.12.1 Unichem Laboratories Company Information
  69. 6.12.2 Unichem Laboratories Business Overview
  70. 6.12.3 Unichem Laboratories Valsartan Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Unichem Laboratories Valsartan Product Portfolio
  72. 6.12.5 Unichem Laboratories Recent Developments
  73. 6.13 Mylan
  74. 6.13.1 Mylan Company Information
  75. 6.13.2 Mylan Business Overview
  76. 6.13.3 Mylan Valsartan Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Mylan Valsartan Product Portfolio
  78. 6.13.5 Mylan Recent Developments
  79. 6.14 Novartis
  80. 6.14.1 Novartis Company Information
  81. 6.14.2 Novartis Business Overview
  82. 6.14.3 Novartis Valsartan Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Novartis Valsartan Product Portfolio
  84. 6.14.5 Novartis Recent Developments
  85. 6.15 Sun Pharmaceutical
  86. 6.15.1 Sun Pharmaceutical Company Information
  87. 6.15.2 Sun Pharmaceutical Business Overview
  88. 6.15.3 Sun Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Sun Pharmaceutical Valsartan Product Portfolio
  90. 6.15.5 Sun Pharmaceutical Recent Developments
  91. 6.16 Teva
  92. 6.16.1 Teva Company Information
  93. 6.16.2 Teva Business Overview
  94. 6.16.3 Teva Valsartan Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Teva Valsartan Product Portfolio
  96. 6.16.5 Teva Recent Developments
  97. 6.17 Zhejiang Huahai Pharmaceutical
  98. 6.17.1 Zhejiang Huahai Pharmaceutical Company Information
  99. 6.17.2 Zhejiang Huahai Pharmaceutical Business Overview
  100. 6.17.3 Zhejiang Huahai Pharmaceutical Valsartan Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Zhejiang Huahai Pharmaceutical Valsartan Product Portfolio
  102. 6.17.5 Zhejiang Huahai Pharmaceutical Recent Developments
7 North America by Country
  1. 7.1 North America Valsartan Sales by Country
  2. 7.1.1 North America Valsartan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Valsartan Sales by Country (2021-2026)
  4. 7.1.3 North America Valsartan Sales Forecast by Country (2027-2032)
  5. 7.2 North America Valsartan Market Size by Country
  6. 7.2.1 North America Valsartan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Valsartan Market Size by Country (2021-2026)
  8. 7.2.3 North America Valsartan Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Valsartan Sales by Country
  2. 8.1.1 Europe Valsartan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Valsartan Sales by Country (2021-2026)
  4. 8.1.3 Europe Valsartan Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Valsartan Market Size by Country
  6. 8.2.1 Europe Valsartan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Valsartan Market Size by Country (2021-2026)
  8. 8.2.3 Europe Valsartan Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Valsartan Sales by Country
  2. 9.1.1 Asia-Pacific Valsartan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Valsartan Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Valsartan Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Valsartan Market Size by Country
  6. 9.2.1 Asia-Pacific Valsartan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Valsartan Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Valsartan Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Valsartan Sales by Country
  2. 10.1.1 South America Valsartan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Valsartan Sales by Country (2021-2026)
  4. 10.1.3 South America Valsartan Sales Forecast by Country (2027-2032)
  5. 10.2 South America Valsartan Market Size by Country
  6. 10.2.1 South America Valsartan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Valsartan Market Size by Country (2021-2026)
  8. 10.2.3 South America Valsartan Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Valsartan Sales by Country
  2. 11.1.1 Middle East and Africa Valsartan Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Valsartan Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Valsartan Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Valsartan Market Size by Country
  6. 11.2.1 Middle East and Africa Valsartan Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Valsartan Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Valsartan Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Valsartan Value Chain Analysis
  2. 12.1.1 Valsartan Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Valsartan Production Mode & Process
  7. 12.2 Valsartan Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Valsartan Distributors
  10. 12.2.3 Valsartan Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst